Stock Photo - dpatop - 02 May 2023, Rhineland-Palatinate, Ingelheim: German Chancellor Olaf Scholz (SPD, r) places a model of an empagliflozin molecule, which is the most important component of the type 2 diabetes drug Jardiance, in a time capsule held by Hubertus von Baumbach, Chairman of the Board of Managing Directors of Boehringer Ingelheim, during the groundbreaking ceremony for Boehringer Ingelheim's Chemical Innovation Plant (CIP). Standing next to them is Malu Dreyer (SPD), Minister President of Rhineland-Palatinate. At the new plant, Boehringer Ingelheim will develop new chemical manufacturing processes for innovative active pharmaceutical ingredients. Photo: Sebastian Christoph Gollnow/dpa. - Ingelheim/Rhineland-Palatinate/Germany

Stock Photo: dpatop - 02 May 2023, Rhineland-Palatinate, Ingelheim: German Chancellor Olaf Scholz (SPD, r) places a model of an empagliflozin molecule.

Searchable keywords

Choose multiple keywords